SPANJAART, AM, P LJUNGMAN, La Camara R DE, G TRIDELLO, V ORTIZ-MALDONADO, A URBANO-ISPIZUA, P BARBA, M KWON, D CABALLERO, P SESQUES, E BACHY, Blasi R DI, C THIEBLEMONT, F CALKOEN, P MUTSAERS, J MAERTENS, L GIANNONI, E NICHOLSON, M COLLIN, CP VAZ, E METAFUNI, J MARTINEZ-LOPEZ, FL DIGNAN, JM RIBERA, A NAGLER, František FOLBER, R SANDERSON, A BLOOR, F CICERI, N KNELANGE, F AYUK, N KROGER, MJ KERSTEN and S MIELKE. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. Leukemia. London: Nature Publishing Group, 2021, vol. 35, No 12, p. 3585-3588. ISSN 0887-6924. Available from: https://dx.doi.org/10.1038/s41375-021-01466-0. |
Other formats:
BibTeX
LaTeX
RIS
@article{1810318, author = {Spanjaart, AM and Ljungman, P and de, La Camara R and Tridello, G and OrtizandMaldonado, V and UrbanoandIspizua, A and Barba, P and Kwon, M and Caballero, D and Sesques, P and Bachy, E and Di, Blasi R and Thieblemont, C and Calkoen, F and Mutsaers, P and Maertens, J and Giannoni, L and Nicholson, E and Collin, M and Vaz, CP and Metafuni, E and MartinezandLopez, J and Dignan, FL and Ribera, JM and Nagler, A and Folber, František and Sanderson, R and Bloor, A and Ciceri, F and Knelange, N and Ayuk, F and Kroger, N and Kersten, MJ and Mielke, S}, article_location = {London}, article_number = {12}, doi = {http://dx.doi.org/10.1038/s41375-021-01466-0}, language = {eng}, issn = {0887-6924}, journal = {Leukemia}, note = {Bez afiliace k MU.}, title = {Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group}, volume = {35}, year = {2021} }
TY - JOUR ID - 1810318 AU - Spanjaart, AM - Ljungman, P - de, La Camara R - Tridello, G - Ortiz-Maldonado, V - Urbano-Ispizua, A - Barba, P - Kwon, M - Caballero, D - Sesques, P - Bachy, E - Di, Blasi R - Thieblemont, C - Calkoen, F - Mutsaers, P - Maertens, J - Giannoni, L - Nicholson, E - Collin, M - Vaz, CP - Metafuni, E - Martinez-Lopez, J - Dignan, FL - Ribera, JM - Nagler, A - Folber, František - Sanderson, R - Bloor, A - Ciceri, F - Knelange, N - Ayuk, F - Kroger, N - Kersten, MJ - Mielke, S PY - 2021 TI - Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group JF - Leukemia VL - 35 IS - 12 SP - 3585-3588 EP - 3585-3588 PB - Nature Publishing Group SN - 08876924 N1 - Bez afiliace k MU. ER -
SPANJAART, AM, P LJUNGMAN, La Camara R DE, G TRIDELLO, V ORTIZ-MALDONADO, A URBANO-ISPIZUA, P BARBA, M KWON, D CABALLERO, P SESQUES, E BACHY, Blasi R DI, C THIEBLEMONT, F CALKOEN, P MUTSAERS, J MAERTENS, L GIANNONI, E NICHOLSON, M COLLIN, CP VAZ, E METAFUNI, J MARTINEZ-LOPEZ, FL DIGNAN, JM RIBERA, A NAGLER, František FOLBER, R SANDERSON, A BLOOR, F CICERI, N KNELANGE, F AYUK, N KROGER, MJ KERSTEN and S MIELKE. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group. \textit{Leukemia}. London: Nature Publishing Group, 2021, vol.~35, No~12, p.~3585-3588. ISSN~0887-6924. Available from: https://dx.doi.org/10.1038/s41375-021-01466-0.
|